Oxford

With preparations underway for a possible vaccine-rollout by January, the Indian drug regulator is looking at the UK, which sources believe may give its nod to the Oxford COVID-19 vaccine next week, before …

Oxford’s COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, the university said on Thursday. …

The study published in the Lancet showed the vaccine had an efficacy of 62 percent for those given two full doses, and of 90 percent in those given a half …

The person’s discharge summary says he was recovering from ‘acute encephalopathy’. A 40-year-old volunteer for ‘Covishield’, the candidate vaccine being tested by the Pune-based Serum Institute of India (SII), has …

The annual ‘Word of the Year’ is a time-honoured tradition. Oxford English Dictionary, in its own tributes, has anointed words that display linguistic flair and ingenious creations in language with …

The vaccine, developed with the University of Oxford, showed 90% efficacy in one dosing regimen — when the vaccine was given as a half dose, followed by a full dose …

The Oxford/AstraZeneca COVID-19 vaccine candidate’s late-stage trial results are “intriguing” and more work needs to be done on the finding that an initial half dose of the shot offers more …

Residents undergo a free rapid antigen nasopharyngeal swab test for Covid-19 at a testing facility set up in a school sports hall, on November 20, 2020 in Bolzano, South Tyrol, …